Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE To compare the published results of studies on the genotype association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V in cases diagnosed as retinal angiomatous proliferation (RAP) versus neovascular age-related macular degeneration (AMD) or healthy controls. 28005184 2017
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE In the subgroup with genotype data, ARMS2 rs10490924 and CFH rs800292 were associated with nAMD. 28120909 2017
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE ARMS2 A69S polymorphism is associated with the number of ranibizumab injections needed for exudative age-related macular degeneration in a pro re nata regimen during 4 years of follow-up. 28744656 2017
Exudative age-related macular degeneration
0.200 GeneticVariation disease GWASCAT Genome-wide association study of neovascular age-related macular degeneration in the Thai population. 28703135 2017
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE Effect of ARMS2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration. 28002601 2016
Exudative age-related macular degeneration
0.200 GeneticVariation disease GWASCAT A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. 26691988 2016
Exudative age-related macular degeneration
0.200 GeneticVariation disease GWASCAT New loci and coding variants confer risk for age-related macular degeneration in East Asians. 25629512 2015
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study. 26132079 2015
Exudative age-related macular degeneration
0.200 Biomarker disease BEFREE In this study, we found that the interaction of ARMS2 and ARMS2/HTRA1 is significantly associated with nAMD, and the interaction of CFH and ARMS2 is pronounced in PCV development in Chinese population. 25771815 2015
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration. 25695752 2015
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE Twelve polymorphisms at the ARMS2-HTRA1 locus showed significant differences between PCV and nAMD. 26081444 2015
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE A study was undertaken to investigate the association between A69S in age-related maculopathy susceptibility 2 (ARMS2) and the response to anti-angiogenesis treatment in exudative age-related macular degeneration (AMD). 25185256 2015
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE This study revealed significant relationships between the plasma MDA level and ARMS2 variants and phenotypes in PCV and nAMD. 24240564 2014
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE Gene-gene interactions of CFH and LOC387715/ARMS2 with Korean exudative age-related macular degeneration patients. 23289807 2013
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE After adjusting for rs11200638, ARMS2 rs10490924 remained significantly associated with nAMD and PCV (p<0.001). 23326481 2013
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE The variants in CFH, ARMS2 and near HTRA1 were strongly associated with both PCV (P < 10(-6), 10(-7) and 10(-7) respectively) and nAMD (P < 10(-6), 10(-16) and 10(-17) respectively). 23274582 2013
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE Three previously reported associations of response to VEGF inhibition in nAMD involving single nucleotide polymorphisms (SNPs) at the CFH, FZD4, and HTRA1/ARMS2 loci were tested for replication. 24070809 2013
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE differentiate the associations of exudative age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) with the ARMS2/HTRA1 locus. 22491416 2012
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE A69S and R38X ARMS2 and Y402H CFH gene polymorphisms as risk factors for neovascular age-related macular degeneration in Poland - a brief report. 22293892 2012
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE Association of ARMS2 genotype with bilateral involvement of exudative age-related macular degeneration. 22809783 2012
Exudative age-related macular degeneration
0.200 GeneticVariation disease GWASCAT Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. 22705344 2012
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE The association of age-related maculopathy susceptibility 2 polymorphisms with phenotype in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. 21541271 2011
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE To investigate whether the A69S variant of the age-related maculopathy susceptibility 2 gene (ARMS2) has a different hereditary contribution in neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV). 22219653 2011
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE To compare the genomic contribution of the ARMS2/HTRA1 region of chromosome 10q26 to typical neovascular age-related macular degeneration (nAMD) (also known as typical exudative AMD) and to polypoidal choroidal vasculopathy (PCV) METHODS: DNA samples were prepared from 84 patients with typical nAMD, 181 patients with PCV, and 276 control participants. 21191724 2010
Exudative age-related macular degeneration
0.200 GeneticVariation disease BEFREE To investigate the effect of single nucleotide polymorphisms (SNPs) and haplotypes in the genes encoding age-related maculopathy susceptibility 2 (LOC387715/ARMS2) and high-temperature requirement A-1 (HTRA1) in a case-control study in a Chinese cohort of individuals with exudative age-related macular degeneration (AMD). 19491722 2009